Clinically Viable Gene Expression Assays with Potential for Predicting Benefit from MEK Inhibitors
暂无分享,去创建一个
J. Barrett | J. Dry | D. Hodgson | Paul D. Smith | E. Harrington | C. Womack | A. Sharpe | R. Brant | N. Whalley | T. Liptrot | Nicky Whalley | Tom Liptrot